Fed­er­al judge rules against FDA in ma­jor stem cell over­sight case

3 years ago
FDA+
Law

Once val­ued at more than $5B, Intar­cia Ther­a­peu­tics sees all of its ex­ecs de­part and its fi­nal shot at FDA de­nied

3 years ago
Pharma
FDA+

An­nu­al brand plan­ning un­der­way, but it’s about time for a dis­rup­tion, says for­mer Big Phar­ma com­mer­cial leader

3 years ago
Pharma
Marketing

Cur­rax dou­bles down on ‘pi­o­neer’ weight-loss med Con­trave in new­ly en­er­gized obe­si­ty drug mar­ket

3 years ago
Pharma
Marketing

West Phar­ma­ceu­ti­cal adds $65M and 225 jobs to Penn­syl­va­nia-based man­u­fac­tur­ing site

3 years ago
Manufacturing

Sanofi's Paul Hud­son scores an FDA OK for a rare dis­ease drug — af­ter a lengthy R&D odyssey

3 years ago
Pharma
FDA+

ICER reaf­firms Qsymia as most cost-ef­fec­tive obe­si­ty treat­ment in fi­nal re­port

3 years ago
Pharma

A $280M life sci­ence fa­cil­i­ty is com­ing to Col­orado as it gains more in­ter­est from biotech de­vel­op­ers

3 years ago
R&D
Pharma

FDA clears Pfiz­er and Mod­er­na's bi­va­lent boost­ers, seek­ing to slow the next wave of Omi­cron

3 years ago
Coronavirus

Af­ter dis­ap­point­ing Wall Street last year, De­nali touts new bio­mark­er da­ta hop­ing to forge clear path to FDA

3 years ago
R&D
FDA+

Af­ter ditch­ing elec­tric ve­hi­cle parts mak­er, a SPAC choos­es a Brown spin­out that had test­ed the IPO wa­ters

3 years ago
Deals

Sau­di an­ti-ag­ing group links up with AFAR to dole out re­search grants; US cannabis biotech se­cures UK part­ner

3 years ago
News Briefing

‘Share­hold­ers de­serve bet­ter’: Mereo lays off em­ploy­ees, push­es back against lead stake­hold­er's shake­up ...

3 years ago
People

Im­muno­Gen push­es read­out of rare blood can­cer tri­al to 2024

3 years ago
R&D

US ex­pects to soon run out of gov­ern­ment Covid-19 funds for vac­cines, treat­ments

3 years ago
Coronavirus

De­spite mar­ket head­winds, life sci­ences re­al es­tate is still on the rise, new re­port says

3 years ago
R&D

No­var­tis' En­tresto in­fringes on uni­ver­si­ty patents, law­suit claims

3 years ago
Pharma
Law

From Aus­tralia, new $173M re­search cen­ter strives to be at the fore­front of pan­dem­ic drug dis­cov­ery

3 years ago
Discovery
Coronavirus

Mi­cro­cap car­dio play­er touts a 'siz­able' tech deal with Bay­er's Blue­Rock in wake of 'go­ing con­cern' alert

3 years ago
Deals

Am­gen posts terse up­date on PhI­II Lumakras win — but just how big?

3 years ago
R&D
Pharma

Phar­ma-backed pa­tient groups sue HHS over co­pay as­sis­tance pro­grams

3 years ago
FDA+
Law

Flori­da sues FDA over drag­ging its feet on Cana­di­an drug im­port pro­gram's ap­proval

3 years ago
Pharma
FDA+

Cor­rect­ed: FDA al­lows Curis to restart en­rolling pa­tients in leukemia tri­al as shares tum­ble 9%

3 years ago
Pharma
FDA+

Aus­tralian man­u­fac­tur­er ac­quired by cap­i­tal in­vest­ment firm with ex­pe­ri­ence in CD­MO space

3 years ago
Deals
Manufacturing
First page Previous page 464465466467468469470 Next page Last page
A service from the Financial Times